LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Molecular Standards Facilitate Assay Development, Validation, and Monitoring

By LabMedica International staff writers
Posted on 25 Nov 2013
A new line of microbial molecular standards includes 13 standards for microorganisms that are difficult to grow or cannot be cultured, such as Cryptosporidium and Norovirus.

Microbiologics (St. Cloud, MN, USA) now offers the new molecular standards line—“Helix Elite.” The new line was introduced at the November 2013 Association for Molecular Pathology’s Annual Meeting (Phoenix, AZ, USA) and is the first product available from Microbiologics’ newly-formed Molecular Products and Services Division, led by the division’s vice president, Brian Beck.

These synthetic standards are developed using a unique patented bioinformatic algorithm that combines the genetic diversity of diagnostic sequences from the target organism. Helix Elite standards can be used as internal or external positive controls in a defined reaction or spiked into matrices and are applicable for a broad range of assays and instruments. “The Helix Elite molecular standards are a safe alternative to using infectious materials that are otherwise hard to access,” said VP Mr. Beck.

Microbiologics’ CEO Brad Goskowicz commented, “Microbiologics is leveraging its experience as a global provider of microbial cultures and reagents to provide innovative products of the highest quality to support molecular diagnostics. With the addition of Helix Elite, Microbiologics is now positioned to offer a full-line of controls, from microorganisms and attenuated strains to genomic and synthetic molecular standards.”

Related Links:
Microbiologics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Urinalysis Solution
UN-9000
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest Pathology News

AI Tool Identifies Slide Artifacts to Speed Digital Pathology Diagnosis
25 Nov 2013  |   Pathology

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis
25 Nov 2013  |   Pathology

AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer
25 Nov 2013  |   Pathology